Skip to main content
Top
Published in: Trials 1/2009

Open Access 01-12-2009 | Study protocol

Protocol for the PINCER trial: a cluster randomised trial comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices

Authors: Anthony J Avery, Sarah Rodgers, Judith A Cantrill, Sarah Armstrong, Rachel Elliott, Rachel Howard, Denise Kendrick, Caroline J Morris, Scott A Murray, Robin J Prescott, Kathrin Cresswell, Aziz Sheikh

Published in: Trials | Issue 1/2009

Login to get access

Abstract

Background

Medication errors are an important cause of morbidity and mortality in primary care.
The aims of this study are to determine the effectiveness, cost effectiveness and acceptability of a pharmacist-led information-technology-based complex intervention compared with simple feedback in reducing proportions of patients at risk from potentially hazardous prescribing and medicines management in general (family) practice.

Methods

Research subject group: "At-risk" patients registered with computerised general practices in two geographical regions in England.
Design: Parallel group pragmatic cluster randomised trial.
Interventions: Practices will be randomised to either: (i) Computer-generated feedback; or (ii) Pharmacist-led intervention comprising of computer-generated feedback, educational outreach and dedicated support.
Primary outcome measures: The proportion of patients in each practice at six and 12 months post intervention:
- with a computer-recorded history of peptic ulcer being prescribed non-selective non-steroidal anti-inflammatory drugs
- with a computer-recorded diagnosis of asthma being prescribed beta-blockers
- aged 75 years and older receiving long-term prescriptions for angiotensin converting enzyme inhibitors or loop diuretics without a recorded assessment of renal function and electrolytes in the preceding 15 months.
Secondary outcome measures; These relate to a number of other examples of potentially hazardous prescribing and medicines management.
Economic analysis: An economic evaluation will be done of the cost per error avoided, from the perspective of the UK National Health Service (NHS), comparing the pharmacist-led intervention with simple feedback.
Qualitative analysis: A qualitative study will be conducted to explore the views and experiences of health care professionals and NHS managers concerning the interventions, and investigate possible reasons why the interventions prove effective, or conversely prove ineffective.
Sample size: 34 practices in each of the two treatment arms would provide at least 80% power (two-tailed alpha of 0.05) to demonstrate a 50% reduction in error rates for each of the three primary outcome measures in the pharmacist-led intervention arm compared with a 11% reduction in the simple feedback arm.

Discussion

At the time of submission of this article, 72 general practices have been recruited (36 in each arm of the trial) and the interventions have been delivered. Analysis has not yet been undertaken.

Trial registration

Current controlled trials ISRCTN21785299
Appendix
Available only for authorised users
Literature
1.
go back to reference Department of Health: An organisation with a memory: report of an expert group on learning from adverse events in the NHS. 2000, London: Department of Health Department of Health: An organisation with a memory: report of an expert group on learning from adverse events in the NHS. 2000, London: Department of Health
2.
go back to reference Kohn L, Corrigan J, Donaldson M: To err is human-building a safer health system. 1999, Washington DC: Committee on Quality of Health Care in America, Institute of Medicine Kohn L, Corrigan J, Donaldson M: To err is human-building a safer health system. 1999, Washington DC: Committee on Quality of Health Care in America, Institute of Medicine
3.
go back to reference Department of Health: Building a safer NHS for patients: implementing an organisation with a memory. 2000, London: Department of Health Department of Health: Building a safer NHS for patients: implementing an organisation with a memory. 2000, London: Department of Health
4.
go back to reference Smith J: Building a safer NHS for patients: improving medication safety. 2004, London: Department of Health Smith J: Building a safer NHS for patients: improving medication safety. 2004, London: Department of Health
7.
go back to reference Avery AJ, Sheikh A, Hurwitz B, Smeaton L, Chen Y-F, Howard RL, Cantrill J, Royal S: Safer medicines management in primary care. Br J Gen Pract. 2002, 52: S17-S22.PubMedPubMedCentral Avery AJ, Sheikh A, Hurwitz B, Smeaton L, Chen Y-F, Howard RL, Cantrill J, Royal S: Safer medicines management in primary care. Br J Gen Pract. 2002, 52: S17-S22.PubMedPubMedCentral
8.
go back to reference Royal S, Smeaton L, Avery AJ, Hurwitz B, Sheikh AI: Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care. 2006, 15: 23-31. 10.1136/qshc.2004.012153.CrossRefPubMedPubMedCentral Royal S, Smeaton L, Avery AJ, Hurwitz B, Sheikh AI: Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care. 2006, 15: 23-31. 10.1136/qshc.2004.012153.CrossRefPubMedPubMedCentral
9.
go back to reference Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, Pirmohamed M: Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007, 63: 136-147. 10.1111/j.1365-2125.2006.02698.x.CrossRefPubMed Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, Pirmohamed M: Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007, 63: 136-147. 10.1111/j.1365-2125.2006.02698.x.CrossRefPubMed
10.
go back to reference Howard RL, Avery AJ, Howard PD, Partridge M: Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care. 2003, 12: 280-285. 10.1136/qhc.12.4.280.CrossRefPubMedPubMedCentral Howard RL, Avery AJ, Howard PD, Partridge M: Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care. 2003, 12: 280-285. 10.1136/qhc.12.4.280.CrossRefPubMedPubMedCentral
11.
go back to reference Chen YF, Avery A, Neil K, Johnson C: Assessing the Occurrence and Preventability of prescribing potentially hazardous/contraindicated drug combinations in general (family) practice. Pharmacoepidemiol Drug Saf. 2001, 10 (Suppl 1): S53- Chen YF, Avery A, Neil K, Johnson C: Assessing the Occurrence and Preventability of prescribing potentially hazardous/contraindicated drug combinations in general (family) practice. Pharmacoepidemiol Drug Saf. 2001, 10 (Suppl 1): S53-
12.
go back to reference Shah SN, Aslam M, Avery AJ: A survey of prescription errors in general practice. Pharm J. 2001, 267: 860-862. Shah SN, Aslam M, Avery AJ: A survey of prescription errors in general practice. Pharm J. 2001, 267: 860-862.
13.
go back to reference Joint Formulary Committee: British National Formulary. 2003, London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 46 Joint Formulary Committee: British National Formulary. 2003, London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 46
14.
go back to reference Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, Hallisey R, Ives J, Laird N, Laffel G: Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA. 1995, 274: 35-43. 10.1001/jama.274.1.35.CrossRefPubMed Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, Hallisey R, Ives J, Laird N, Laffel G: Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA. 1995, 274: 35-43. 10.1001/jama.274.1.35.CrossRefPubMed
15.
go back to reference Dean B, Schachter M, Vincent C, Barber N: Causes of prescribing errors in hospital inpatients: a prospective study. Lancet. 2002, 359: 1373-1378. 10.1016/S0140-6736(02)08350-2.CrossRefPubMed Dean B, Schachter M, Vincent C, Barber N: Causes of prescribing errors in hospital inpatients: a prospective study. Lancet. 2002, 359: 1373-1378. 10.1016/S0140-6736(02)08350-2.CrossRefPubMed
16.
go back to reference Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, Bates DW: Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003, 289: 1107-1116. 10.1001/jama.289.9.1107.CrossRefPubMed Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, Bates DW: Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003, 289: 1107-1116. 10.1001/jama.289.9.1107.CrossRefPubMed
18.
go back to reference Morris CJ, Cantrill JA, Bate JR: How the use of preventable drug-related morbidity indicators can improve medicines management in primary care. Pharm J. 2003, 271: 682-686. Morris CJ, Cantrill JA, Bate JR: How the use of preventable drug-related morbidity indicators can improve medicines management in primary care. Pharm J. 2003, 271: 682-686.
19.
go back to reference Morris CJ, Rodgers S, Hammersley VS, Avery AJ, Cantrill JA: Indicators for preventable drug related morbidity: application in primary care. Qual Saf Health Care. 2004, 13: 181-185. 10.1136/qshc.2003.008334.CrossRefPubMedPubMedCentral Morris CJ, Rodgers S, Hammersley VS, Avery AJ, Cantrill JA: Indicators for preventable drug related morbidity: application in primary care. Qual Saf Health Care. 2004, 13: 181-185. 10.1136/qshc.2003.008334.CrossRefPubMedPubMedCentral
20.
go back to reference Medical Research Council: MRC's framework for the development and evaluation of RCT's for complex interventions. 2000, London: Medical Research Council,http://www.mrc.ac.uk Medical Research Council: MRC's framework for the development and evaluation of RCT's for complex interventions. 2000, London: Medical Research Council,http://​www.​mrc.​ac.​uk
21.
go back to reference Soumerai SB, Avorn J: Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA. 1990, 263: 549-556. 10.1001/jama.263.4.549.CrossRefPubMed Soumerai SB, Avorn J: Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA. 1990, 263: 549-556. 10.1001/jama.263.4.549.CrossRefPubMed
22.
go back to reference Wald H, Shojania KG: Root cause analysis. Making healthcare safer: A critical analysis of patient safety practices Evidence report number 43. 2001, Rockville, MD: Agency for Healthcare Research and Quality Wald H, Shojania KG: Root cause analysis. Making healthcare safer: A critical analysis of patient safety practices Evidence report number 43. 2001, Rockville, MD: Agency for Healthcare Research and Quality
23.
go back to reference May FW, Rowett DS, Gilbert AL, McNeece JI, Hurley E: Outcomes of an educational-outreach service for community medical practitioners: non-steroidal anti-inflammatory drugs. Med J Aust. 1999, 170: 471-474.PubMed May FW, Rowett DS, Gilbert AL, McNeece JI, Hurley E: Outcomes of an educational-outreach service for community medical practitioners: non-steroidal anti-inflammatory drugs. Med J Aust. 1999, 170: 471-474.PubMed
24.
go back to reference Freemantle N, Nazareth I, Eccles M, Wood J, Haines A: A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice. Br J Gen Pract. 2002, 52: 290-295.PubMedPubMedCentral Freemantle N, Nazareth I, Eccles M, Wood J, Haines A: A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice. Br J Gen Pract. 2002, 52: 290-295.PubMedPubMedCentral
26.
go back to reference Elashoff JD: nQuery Advisor®Version 6.0 Software. Los Angeles: CA. 2005 Elashoff JD: nQuery Advisor®Version 6.0 Software. Los Angeles: CA. 2005
28.
go back to reference Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD: Audit and feedback: effects on professional practice and health care outcomes. 2004, Chichester, UK: The Cochrane Library Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD: Audit and feedback: effects on professional practice and health care outcomes. 2004, Chichester, UK: The Cochrane Library
29.
go back to reference Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, Cowper PA, Landsman PB, Cohen HJ, Feussner JR: A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996, 100: 428-437. 10.1016/S0002-9343(97)89519-8.CrossRefPubMed Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, Cowper PA, Landsman PB, Cohen HJ, Feussner JR: A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996, 100: 428-437. 10.1016/S0002-9343(97)89519-8.CrossRefPubMed
30.
go back to reference Fish A, Watson MC, Bond CM: Practice-based pharmaceutical services: a systematic review. Int J Pharm Pract. 2002, 10: 225-233. 10.1211/096176702776868451.CrossRef Fish A, Watson MC, Bond CM: Practice-based pharmaceutical services: a systematic review. Int J Pharm Pract. 2002, 10: 225-233. 10.1211/096176702776868451.CrossRef
31.
go back to reference Granås AG, Bates I: The effect of pharmaceutical review of repeat prescriptions in general practice. Int J Pharm Pract. 1999, 7: 264-275.CrossRef Granås AG, Bates I: The effect of pharmaceutical review of repeat prescriptions in general practice. Int J Pharm Pract. 1999, 7: 264-275.CrossRef
32.
go back to reference Mackie CA, Lawson DH, Campbell A, Maclaren AG, Waigh R: A randomised controlled trial of medication review in patients receiving polypharmacy in general practice. Pharm J. 1999, 263: R7- Mackie CA, Lawson DH, Campbell A, Maclaren AG, Waigh R: A randomised controlled trial of medication review in patients receiving polypharmacy in general practice. Pharm J. 1999, 263: R7-
33.
go back to reference Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, Downie G: Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001, 30: 205-211. 10.1093/ageing/30.3.205.CrossRefPubMed Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, Downie G: Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001, 30: 205-211. 10.1093/ageing/30.3.205.CrossRefPubMed
34.
go back to reference Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL: Educational outreach visits: Effects on professional practice and health care outcomes (Cochrane review). The Cochrane Library. 2004, Chichester, UK: John Wiley & Sons Ltd, 1 Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL: Educational outreach visits: Effects on professional practice and health care outcomes (Cochrane review). The Cochrane Library. 2004, Chichester, UK: John Wiley & Sons Ltd, 1
35.
go back to reference Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O'Brien MA: Changing Provider Behavior: An Overview of Systematic Reviews of Interventions. Med Care. 2001, 39: II-2-II-45. 10.1097/00005650-200108002-00002.CrossRef Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O'Brien MA: Changing Provider Behavior: An Overview of Systematic Reviews of Interventions. Med Care. 2001, 39: II-2-II-45. 10.1097/00005650-200108002-00002.CrossRef
38.
go back to reference Assmann SF, Pocock SJ, Enos LE, Kasten LE: Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000, 355: 1064-1069. 10.1016/S0140-6736(00)02039-0.CrossRefPubMed Assmann SF, Pocock SJ, Enos LE, Kasten LE: Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000, 355: 1064-1069. 10.1016/S0140-6736(00)02039-0.CrossRefPubMed
39.
go back to reference Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ: Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. Health Technology Assessment. 1999, 3: doi:10.3310/hta3050 Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ: Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. Health Technology Assessment. 1999, 3: doi:10.3310/hta3050
40.
go back to reference Pocock SJ, Assmann SE, Enos LE, Kasten LE: Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med. 2002, 21: 2917-2930. 10.1002/sim.1296.CrossRefPubMed Pocock SJ, Assmann SE, Enos LE, Kasten LE: Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med. 2002, 21: 2917-2930. 10.1002/sim.1296.CrossRefPubMed
41.
go back to reference Hernández AV, Steyerberg EW, Habbema JD: Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol. 2004, 57: 454-460. 10.1016/j.jclinepi.2003.09.014.CrossRefPubMed Hernández AV, Steyerberg EW, Habbema JD: Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol. 2004, 57: 454-460. 10.1016/j.jclinepi.2003.09.014.CrossRefPubMed
42.
go back to reference Hauck WW, Anderson S, Marcus SM: Should we adjust for covariates in nonlinear regression analyses of randomized trials?. Control Clin Trials. 1998, 19: 249-256. 10.1016/S0197-2456(97)00147-5.CrossRefPubMed Hauck WW, Anderson S, Marcus SM: Should we adjust for covariates in nonlinear regression analyses of randomized trials?. Control Clin Trials. 1998, 19: 249-256. 10.1016/S0197-2456(97)00147-5.CrossRefPubMed
43.
44.
go back to reference Shih WJ: Problems in dealing with missing data and informative censoring in clinical trials. Curr Control Trials Cardiovasc Med. 2002, 3: 4-10.1186/1468-6708-3-4.CrossRefPubMedPubMedCentral Shih WJ: Problems in dealing with missing data and informative censoring in clinical trials. Curr Control Trials Cardiovasc Med. 2002, 3: 4-10.1186/1468-6708-3-4.CrossRefPubMedPubMedCentral
45.
go back to reference StataCorp LP: Stata data analysis and statistical Software. Special Edition Release 10.1 edition. 2008, College Station, Texas: Stata StataCorp LP: Stata data analysis and statistical Software. Special Edition Release 10.1 edition. 2008, College Station, Texas: Stata
46.
go back to reference Snijders TAB, Bosker RJ: Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. 1999, London: Sage Publications Ltd Snijders TAB, Bosker RJ: Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. 1999, London: Sage Publications Ltd
47.
go back to reference Drummond M, MJ S, Torrance G, O'Brien BJ, Stoddart GL: Methods for the economic evaluation of health care programmes. 2005, Oxford: Oxford University Press, 3 Drummond M, MJ S, Torrance G, O'Brien BJ, Stoddart GL: Methods for the economic evaluation of health care programmes. 2005, Oxford: Oxford University Press, 3
48.
go back to reference Flynn TN, Peters TJ: Cluster randomized trials: Another problem for cost-effectiveness ratios. International Journal of Technology Assessment in Health Care. 2005, 21: 403-409. 10.1017/S0266462305050531.CrossRefPubMed Flynn TN, Peters TJ: Cluster randomized trials: Another problem for cost-effectiveness ratios. International Journal of Technology Assessment in Health Care. 2005, 21: 403-409. 10.1017/S0266462305050531.CrossRefPubMed
49.
go back to reference Netten A, Dennett J, (Eds): Unit costs of community care 2007. 2007, Kent, Canterbury: Personal Social Services Research Unit Netten A, Dennett J, (Eds): Unit costs of community care 2007. 2007, Kent, Canterbury: Personal Social Services Research Unit
50.
go back to reference Briggs A, Gray A: The distribution of health care costs and their statistical analysis for economic evaluation. J Health Serv Res Policy. 1998, 3: 233-245.PubMed Briggs A, Gray A: The distribution of health care costs and their statistical analysis for economic evaluation. J Health Serv Res Policy. 1998, 3: 233-245.PubMed
51.
go back to reference van Hout BA, Al MJ, Gordon GS, Rutten FF: Costs, effects and C/E-ratios alongside a clinical trial. Health Econ. 1994, 3: 309-319. 10.1002/hec.4730030505.CrossRefPubMed van Hout BA, Al MJ, Gordon GS, Rutten FF: Costs, effects and C/E-ratios alongside a clinical trial. Health Econ. 1994, 3: 309-319. 10.1002/hec.4730030505.CrossRefPubMed
Metadata
Title
Protocol for the PINCER trial: a cluster randomised trial comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices
Authors
Anthony J Avery
Sarah Rodgers
Judith A Cantrill
Sarah Armstrong
Rachel Elliott
Rachel Howard
Denise Kendrick
Caroline J Morris
Scott A Murray
Robin J Prescott
Kathrin Cresswell
Aziz Sheikh
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Trials / Issue 1/2009
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-10-28

Other articles of this Issue 1/2009

Trials 1/2009 Go to the issue